Abstract
Background:
Crush/imprint cytology, a diagnostic technique within the realm of cytological examinations, has emerged as a powerful tool for rapid and minimally invasive tissue evaluation. Its simplicity, cost-effectiveness, and rapidity make it indispensable in pathology practice.
Aims and Objectives:
The aims and objectives were as follows: (1) to evaluate the diagnostic utility of crush/imprint cytology and (2) to correlate cytomorphological and histopathological (HP) findings for comprehensive diagnostic evaluation.
Materials and Methods:
This prospective study was carried out in a tertiary health care hospital for a period of 1 year, and 56 cases were included in this study. Both benign and malignant lesions from different organ systems were included in this study. The cytological diagnosis was correlated with HP diagnosis to evaluate the sensitivity and specificity of crush cytology.
Results:
This study showed a male predominance (69%). Most lesions were from the respiratory system (33.33%), followed by head and neck (24.07%), lymphoreticular system (16.66%), gastrointestinal system (11.11%), skin (9.25%), and genitourinary system (5.55%). Malignant lesions showed good (44%) cell yield on crush/imprint cytology. The sensitivity was 100%, with 94.12% specificity for detecting benign and malignant lesions, and the overall diagnostic accuracy was 98.15%.
Conclusion:
The crush/imprint cytology stands as a cornerstone in the realm of cellular diagnosis, offering a rapid, cost-effective, and minimally invasive approach to evaluating tissue specimens. It is an indispensable tool in intraoperative diagnostics, offering rapid and accurate assessments of tissue pathology. It acts as a good complement to histopathology and can be of benefit for rapid preliminary diagnosis and intraoperative surgical management planning. Its use is highly recommended routinely.
Keywords: Crush/imprint cytology, diagnostic accuracy, histopathology
INTRODUCTION
Crush/imprint cytology, a technique within the broader field of cytology, serves as a valuable diagnostic tool in various medical specialties. It is a rapid and cost-effective technique that plays a crucial role in the evaluation of specimens from different organ systems. It was introduced in 1927 by Dudgeon and Patrick[1] at the University of London, raising the horizons of the rapid cytological diagnosis of freshly cut specimens. These methods enable quick microscopic evaluation of cells, aiding in immediate surgical decision-making. Crush/imprint smear cytology, commonly used for on-site evaluation of central nervous system lesions, was also reported to be useful in the diagnosis of gastrointestinal malignancies,[2] breast, prostate, lung, liver, lymph node, bone, and soft tissue masses.[3] Besides its speed and enormous simplicity, it provides excellent cellular details.[4] Histopathological examination (HPE) is considered the gold standard for diagnosing lesions in any organ, but delays may occur due to lengthy processing times. Imprint cytology helps to provide rapid diagnosis and save valuable time.[5] This publication provides an overview of crush/imprint cytology, its technique, applications, diagnostic utility in various clinical settings, and emphasizes its significance in providing immediate feedback during on-site evaluation, facilitating real-time decision-making in patient management. Additionally, the publication discusses the advantages, limitations, and future perspectives of crush/imprint cytology in cytological practice.
Aims and objectives
The aims and objectives were as follows:
To evaluate the diagnostic utility of crush/imprint cytology.
To correlate cytomorphological and histopathological (HP) findings for comprehensive diagnostic evaluation.
MATERIALS AND METHODS
This is a prospective observational study carried out for the period of 1 year at a tertiary health care center. A total of 56 cases of tumors and tumor-like lesions from various organ systems were included, which were clinically indicated. Inclusion was limited to cases where fresh tissue was available, and HP correlation was possible, ensuring diagnostic accuracy but resulting in a smaller, targeted sample size. Fresh specimens were sent from operation theater either on a wet gauze or in normal saline. Specimens sent in formalin were not included in this study. In each case, data were collected prospectively, and complete clinico-radiological details were recorded. Gross pathological features were recorded before crush/imprints were prepared. Using filter paper, excess blood or normal saline was soaked up. Touch imprints were prepared by touching the freshly cut, flat surface of the specimen on a glass slide gently but with firm pressure twice or thrice.[6] For preparing crushed smears, the tissue was gently crushed between the two glass slides. A slide used for crushing tissue was kept at a right angle to the slide on which tissue was placed. This method involves the application of pressure to a tissue specimen, resulting in cellular disruption and release, facilitating microscopic examination.
Both wet and dry smears were prepared. Wet smears were fixed immediately in 95% ethyl alcohol and stained by rapid hematoxylin and eosin and Papanicolaou stain. Air-dried smears were stained by May–Grunwald–Giemsa stain. The smears were examined for cell morphology, nuclear and cytoplasmic details, which help in facilitating the identification of abnormalities indicative of underlying pathology.
The cytological diagnosis was correlated with histopathology, which was considered the gold standard. The sensitivity, specificity, positive predictive value, and negative predictive value of crush/imprint were calculated. The diagnostic accuracy of crush/imprint cytology was established.
RESULTS
A total of 56 patients were included in the study. Out of these, two specimens were inadequate for interpretation; therefore, results were calculated on 54 cases. Comparison between crush/imprint and histopathology diagnosis was done.
Male predominance was observed in 37 (69%) cases, and females were 17 (31%). In this study, age ranged from 6 to 84 years. Most of the patients were in the age group of 41–60 years (50%). Only five cases were in the age group of ≤20 years. Mean age was 48.72 years [Figure 1].
Figure 1.

Age-wise distribution of cases (n = 54)
Out of 54 cases; maximum number of samples received for diagnostic purpose 38 (70.37%), and 16 (29.62%) samples were received intraoperatively for rapid on-site evaluation [Figure 2].
Figure 2.

Distribution of cases in diagnostic and intraoperative specimens (n = 54)
Lesions from different organ systems were included. Maximum lesions were from the respiratory system (33.33%), followed by head and neck (24.07%), lymphoreticular system (16.66%), gastrointestinal system (11.11%), skin (9.25%), and genitourinary system (5.55%; Figure 3).
Figure 3.
System-wise distribution of the cases among the study population (n = 54)
System-wise diagnosis of individual cases on crush/imprint cytology and histopathology is shown in Table 1 and Figures 4,5,6,7,8,9,10,11,12.
Table 1.
System-wise distribution of the cases with their diagnoses (n = 54)
| Systems | Crush/imprint cytology | Histopathology | ||
|---|---|---|---|---|
| Diagnosis | No | Diagnosis | No | |
| Head and neck (13) | Mild atypia | 2 | No e/o malignancy | 2 |
| Dysplasia (mild, moderate, severe) | 8 | Squamous cell carcinoma | 8 | |
| Small round cell tumor of the submandibular gland | 1 | Small round cell tumor | 1 | |
| Papillary adenoma of the endolymphatic sac | 1 | Papillary adenoma of the endolymphatic sac | 1 | |
| Chronic lymphocytic thyroiditis | 1 | Hashimoto’s disease | 1 | |
| Lymphoreticular (09) | Reactive lymphadenitis | 2 | Reactive lymphadenitis | 2 |
| Chronic tonsilitis | 1 | Chronic tonsilitis | 1 | |
| Metastasis of poorly differentiated malignancy | 4 | Metastases of squamous cell carcinoma | 4 | |
| Metastasis of epithelial malignancy | 1 | Metastasis of mucoepidermoid carcinoma | 1 | |
| Metastasis of papillary carcinoma of the thyroid | 1 | Metastasis of papillary carcinoma of the thyroid | 1 | |
| Respiratory (18) | Fibrocollagenous tissue with inflammatory infiltrate | 7 | Fibrocollagenous tissue with inflammatory infiltrate Changes of consolidation |
5 2 |
| Small round cell carcinoma | 1 | Small round cell carcinoma | 1 | |
| Non-small round cell carcinoma | 9 | Non-small round cell carcinoma | 9 | |
| Metastasis of poorly differentiated malignancy | 1 | Metastasis of follicular thyroid carcinoma in the lung | 1 | |
| Genitourinary (3) | Suspicious of malignancy | 1 | No evidence of malignancy | 1 |
| Poorly diff. malignancy | 1 | Wilms tumor | 1 | |
| Suspicious of SCC | 1 | Well diff. SCC | 1 | |
| GIT (6) | Necrotizing lesion—tuberculous | 1 | Necrotizing lesion—tuberculous | 1 |
| Squamous cell carcinoma | 5 | Squamous cell carcinoma | 5 | |
| Skin (5) | Dermoid cyst | 2 | Dermoid cyst | 2 |
| Squamous cell carcinoma | 3 | Squamous cell carcinoma | 3 | |
| Total—54 | 54 | 54 | ||
SCC: squamous cell carcinoma
Figure 4.
Mucoepidermoid carcinoma (a) Infra-auricular and Post auricular lymph node. (b) Hematoxylin and eosin (10×) squamous cells (black arrow), intermediate cells (yellow arrow), and mucin-secreting vacuolated cells (red arrow) against a lymphocytic background. (c) Histopathological examination (10×) of the tumor showing squamous cells, intermediate cells, and mucous cells
Figure 5.
Squamous cell carcinoma—sinonasal cavity (a) hematoxylin and eosin (40×) malignant squamous cells scattered in clusters and singly, showing nuclear pleomorphism, high N:C ratio, coarse granular chromatin, irregular nuclear membrane, and prominent nucleoli at places. (b) Histopathological examination (10×) of sheets of malignant squamous cells in stroma with keratin pearls
Figure 6.
Small round cell tumor—submandibular gland (a and b) Hematoxylin and eosin (40×) tumor cells with round cell morphology arranged in clusters, rosettes, and scattered singly. Cells are medium-sized, having scant to no cytoplasm, round nuclei with coarse granular chromatin, and inconspicuous nucleoli in places against a lymphocytic background. (c) histopathological examination (10×) sheets of round cells with a glandular component
Figure 7.
Endolymphatic sac tumor—left mastoid cavity (a) hematoxylin and eosin (10×) epithelial cells arranged in papillary fronds with fibrovascular core and in sheets having round to oval nucleus with bland granular chromatin with moderate eosinophilic cytoplasm. (b) Histopathological examination (10×)—papillary structures lined by bland cuboidal to columnar cells having mild nuclear pleomorphism and clear cytoplasm. Few follicular structures containing homogenous eosinophilic material
Figure 8.
Metastatic deposits of papillary carcinoma thyroid in cervical lymph node (a) midline thyroid swelling with left cervical lymphadenopathy. (b) Hematoxylin and eosin (H&E, 40×) smears showing high cell yield with loose clusters of cells arranged in a papillary pattern with intranuclear grooves (black arrow) and Intranuclear cytoplasmic inclusions (inset). (c) H&E (10×) histopathological examination—showed true complex papillae
Figure 9.
Lung mass—epithelial malignancy favoring squamous cell carcinoma (a and b) Hematoxylin and eosin (H&E, 40×) sheets, clusters, and singly scattered tumor cells having dense eosinophilic cytoplasm, round to oval pleomorphic nucleus with coarse granular chromatin and prominent nucleoli at places. Nuclear overlapping, overcrowding, binucleation, multinucleation, and nuclear membrane irregularity are also noted (c) histopathological examination H&E (40×)—non-small cell carcinoma—sheets of malignant squamous cells with dense eosinophilic cytoplasm, nuclear pleomorphism, mitotic figures at places
Figure 10.
Adenocarcinoma lung (a) Hematoxylin and eosin (H&E, 40×). Atypical tumor cells are arranged in a glandular and occasional acinar pattern. Cells have scant eosinophilic cytoplasm, a round to oval pleomorphic nucleus with coarse granular chromatin and prominent nucleoli. (b) H&E (10×) histopathological examination—glandular arrangement of tumor cells
Figure 11.
Metastasis of follicular thyroid carcinoma in the lung (a) Hematoxylin and eosin (H&E, 40×) smears show a monomorphic population of round cells in clusters, groups, follicles, occasional sheets, and singly scattered. Cells have scanty cytoplasm with small, round, monomorphic nuclei with coarse granular chromatin and inconspicuous nucleoli in places. (b) Histopathological examination (10×) of the lung biopsy from shows thyroid follicles lined by cuboidal epithelium and follicles containing colloid
Figure 12.
Wilms tumor (a) Hematoxylin and eosin (40×), loosely cohesive sheets and singly scattered small blastemal cells having round hyperchromatic nuclei and a moderate amount of cytoplasm. (b) Histopathological examination—blastemal component
Cases were broken down into benign and malignant lesions on crush/imprint cytology and histopathology. The majority of cases were malignant in both [Table 2].
Table 2.
Breakdown of cases on crush/imprint cytology and histopathological examination
| Crush/imprint cytology | Histopathology | |||
|---|---|---|---|---|
| No. of cases | % | No. of cases | % | |
| Malignant | 38 | 70.37 | 37 | 68.52 |
| Benign | 16 | 29.63 | 17 | 31.48 |
| Total | 54 | 100 | 54 | 100 |
To assess the correlation between crush/imprint cytology and HPE, malignant and benign cases were organized into a 2 × 2 contingency table [Table 3]. Thirty-eight malignant lesions and 16 benign lesions were correctly diagnosed by crush/imprint cytology. One case was identified as a false positive on crush/imprint cytology, but HPE confirmed it as benign.
Table 3.
Association between crush/imprint and histopathological examination
| Crush/imprint cytology | HPE | Total | |
|---|---|---|---|
| Malignant (+) | Benign (−) | ||
| Malignant (+) | 37 | 01 | 38 |
| Benign (−) | 00 | 16 | 16 |
| Total | 37 | 17 | 54 |
HPE: histopathological examination
Crush/imprint, thus showing sensitivity of 100% with 94.12% specificity. Positive predictive value of crush/imprint was 97.37%, negative predictive value was 100%, and diagnostic accuracy was 98.15% [Table 4].
Table 4.
Diagnostic estimation of crush/imprint cytology
| Parameters | Estimates (%) | At 95% confidence interval |
|---|---|---|
| Sensitivity | 100 | 90.51–100 |
| Specificity | 94.12 | 71.31–99.85 |
| Positive predictive value | 97.37 | 84.68–99.60 |
| Negative predictive value | 100 | 79.41–100 |
| Diagnostic accuracy | 98.15 | 90.11–99.95 |
DISCUSSION
Crush/imprint cytology are key diagnostic technique in the realm of pathology, offering quick microscopic analysis, especially in intraoperative settings where immediate results are needed for surgical decisions. The analysis involved 54 specimens, with males representing 67% of cases. Results aligned with studies by Gore et al.[5] and Dutta et al.[7] The majority of cases were in the 41–60 years age range [Figure 1], with most malignant lesions observed in older individuals, consistent with study findings of Gore et al.[5] and Baro et al.[8]
In this study, 70.37% of the lesions were malignant [Figure 2], consistent with findings by Gandhi[9] and Ranjan et al.[10].
Most lesions (33.33%) were from the respiratory system, with non-small cell carcinoma [squamous cell carcinoma and adenocarcinoma—[Figures 9 and 10] being the most common malignancies [Figure 3], aligning with observations by Baro et al.[8] on lung malignancy squash smear cytology.
Thirty-seven cases were identified as malignant by both crush/imprint cytology and HPE [Table 3]. This suggests that crush/imprint cytology is effective in identifying malignant cases. In one case, which was given a suspicious diagnosis of malignancy on crush cytology, the HP diagnosis was benign. The outcome in this case was unable to be determined due to loss of follow-up. This represents a false positive, indicating a possible overdiagnosis in a small number of cases. False-positive results can occur due to reactive atypia, crush artifacts, or overinterpretation of cellular abnormalities. No cases were identified as benign by crush/imprint cytology, but later confirmed as malignant by HPE. This indicates no missed malignant cases, demonstrating the high sensitivity of the test. Sixteen cases were identified as benign by both methods. This confirms the accuracy of crush/imprint cytology in detecting benign cases.
The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of crush cytology in this study were 100%, 94.1%, 97.3%, 100%, and 98.15%, respectively [Table 4]. Several landmark studies have also assessed the efficacy of crush and imprint cytology in various malignancies.
Dudgeon and Patrick[1] pioneered the use of crush cytology and reported a sensitivity of approximately 90%, marking a significant advancement in rapid tumor diagnosis. The specificity was slightly lower, around 85%, due to challenges in differentiating benign from malignant cells in certain cases.[1] In contrast, recent studies like those by Desai et al.[2] and Kubik et al.[3] have focused on specific applications and modern advancements in these techniques. In comparison, Desai et al.[2] reported a higher sensitivity of 93% and specificity of 87% for gastrointestinal malignancies, reflecting improvements in technique and interpretation over the decades. Suen et al.[4] highlighted the high sensitivity (85%–95%) and specificity (90%–95%) of imprint cytology, particularly in intraoperative settings. These findings are corroborated by Gore et al.,[5] who reported similar high sensitivity (92%) and specificity (94%) across various tissue types, particularly effective in breast and thyroid evaluations. In a study done by Olasode and Ironside,[11] the utility of crush cytology for brain tumors was emphasized, reporting a sensitivity of 95%, particularly valuable in resource-limited settings. Jaiswal and Gadkari[6] reported 75% sensitivity and 89.6% specificity in intraoperative cancer diagnosis.
This study demonstrated a diagnostic accuracy of 98.15% for both benign and malignant lesions, correlating with HP findings. These results align with other studies on diagnostic and intraoperative evaluations of individual and combined organ systems.[2,5,10,12] Some studies reported diagnostic accuracy ranging from 75% to 88%, attributing inaccuracies to low cellular yield in benign tumors, leading to erroneous diagnoses.[6,7]
Reported ranges of sensitivity was 80%–95%, specificity was 85%–98%, and diagnostic accuracy was 85%–95%, which makes this test reliable for intraoperative and preliminary diagnoses.
This study did not compare results with frozen sections, though the literature highlights the advantages of cytology in resource-limited settings.[11] Additionally, this method conserves tissue and avoids freezing artifacts, offering a distinct advantage over frozen section analysis.[13]
Crush and imprint cytology consistently demonstrate high accuracy, sensitivity, and specificity (85%–95%) and have evolved with improved diagnostic capabilities since their inception. However, variability across studies underscores the need for standardized protocols and further research.
Advantages and limitations
Crush/imprint cytology offers rapid turnaround, enabling prompt diagnosis and timely management decisions. It is particularly useful for diagnosing malignancies in challenging locations like the central nervous system and deep-seated organs, where traditional biopsies may be impractical or risky.
It offers a minimally invasive alternative to conventional tissue biopsy, reducing patient discomfort and procedural complications. This cost-effective method avoids the need for cryostat machines, making it ideal for resource-limited settings.[14]
However, limitations include potential cellular artifacts, inability to assess tissue architecture, distinguish in situ from invasive carcinomas, evaluate depth of invasion, and poor cellular yield in fibrotic cases, requiring correlation with clinical and radiological findings.
One of the limitations of our study is the small sample size, which is a result of strict inclusion criteria. As a tertiary care center, while we receive a broad spectrum of referred cases, not all are suitable for crush or imprint cytology, which is typically employed in specific intraoperative or deep-seated lesion assessments. Additionally, factors such as preoperative diagnosis methods and the feasibility of obtaining adequate fresh tissue for imprint preparation further restricted the sample pool. Furthermore, only those cases with confirmed HP diagnoses—the gold standard—were included for definitive correlation, thereby ensuring diagnostic accuracy and methodological validity. This selective approach, though restrictive, was crucial for meaningful cytological–HP correlation and reliable interpretation. The small sample size limits the generalizability of our findings. However, it reflects the real-world application of crush/imprint cytology in a tertiary care setting, where such procedures are used selectively and under specific clinical circumstances.
CONCLUSION
Crush/imprint cytology stands as a cornerstone in the realm of cellular diagnosis, offering a rapid, cost-effective, and minimally invasive approach for evaluating tissue specimens. These techniques demonstrate consistently high sensitivity, specificity, and diagnostic accuracy, despite their limitations, which can be further enhanced and confirmed by gross and radiological findings. It helps to provide timely and accurate diagnoses, improving intraoperative patient management, and preventing unnecessary or inadequate surgeries. These techniques cannot entirely substitute HPE for definitive tumor typing, grading, and confirming invasion, but it acts as an added asset to the histology to maximize diagnostic accuracy and accelerate decision-making for the management of lesions. Despite the limited number of cases, the study provides valuable insights into the diagnostic utility of crush/imprint cytology, laying the groundwork for larger, multicenter studies in the future.
Integration with ancillary techniques, such as immunocytochemistry and molecular testing, could further refine their diagnostic performance and broaden their applications.
Conflicts of interest
There are no conflicts of interest.
Funding Statement
Nil.
REFERENCES
- 1.Dudgeon LS, Patrick CV. A new method for the rapid microscopical diagnosis of tumours: With an account of 200 cases so examined. J Br Surg. 1927;15:250–61. [Google Scholar]
- 2.Desai P, Kabrawala M, Patel C, Arora P, Mehta R, Nandwani S, et al. Crush cytology: An expeditious diagnostic tool for gastrointestinal tract malignancy. Endosc Int Open. 2021;9:E735–40. doi: 10.1055/a-1388-6479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kubik MJ, Bovbel A, Goli H, Saremian J, Siddiqi A, Masood S. Diagnostic value and accuracy of imprint cytology evaluation during image-guided core needle biopsies: Review of our experience at a large academic center. Diagn Cytopathol. 2015;43:773–9. doi: 10.1002/dc.23300. [DOI] [PubMed] [Google Scholar]
- 4.Suen KC, Wood WS, Syed AA, Quenville NF, Clement PB. Role of imprint cytology in intraoperative diagnosis: Value and limitations. J Clin Pathol. 1978;31:328–37. doi: 10.1136/jcp.31.4.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gore C, Singh B, Chandanwale S, Gurwale S, Kumar H, Bawikar R, et al. Imprint cytology: A boon in tissue diagnosis. Med J DY Patil Univ. 2017;10:58–63. [Google Scholar]
- 6.Jaiswal Y, Gadkari R. Evaluation of role of intraoperative cytology technique in diagnosis and management of cancer. J Cytol. 2020;37:126–30. doi: 10.4103/JOC.JOC_94_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dutta SK, Dasgupta S, Bhattacharyya NK, Jain P, Bose D, Biswas PK. Comparative study of imprint cytology and histopathology of soft tissue tumors. Indian J Med Paediatr Oncol. 2017;38:461–5. doi: 10.4103/ijmpo.ijmpo_132_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Baro B, Lad SK, Utpat K, Saha A. The diagnostic utility of squash smear cytology in lung malignancies. Egypt J Bronchol. 2022;16:40. [Google Scholar]
- 9.Gandhi DS. Role of imprint cytology in the diagnosis of malignant lesions – A hospital-based study. Journal of Medical Science And clinical Research. 2018;6 doi: 10.18535/jmscr/v6i7.48. [DOI] [Google Scholar]
- 10.Ranjan A, Chandoke RK, Chauhan N, Kumari R. Oncology study of tumors by imprint cytology. Indian J Clin Pract. 2013;24:472–5. [Google Scholar]
- 11.Olasode BJ, Ironside JW. The brain smear, a rapid affordable intraoperative diagnostic technique for brain tumours appropriate for Africa. Trop Doct. 2004;34:223–5. doi: 10.1177/004947550403400412. [DOI] [PubMed] [Google Scholar]
- 12.Karre S, Veeragandham S, Kalahasti R, Salma M, Kumar DA, Mohammed H. Importance of intraoperative-touch imprint cytology in the diagnosis of neoplastic lesions of breast. IOSR J Dent Med Sci. 2015;14:5–12. [Google Scholar]
- 13.Creager AJ, Shaw JA, Young PR, Geisinger KR. Intraoperative imprint cytology of lumpectomy margins. Arch Pathol Lab Med. 2002;126:846–8. doi: 10.5858/2002-126-0846-IEOLMB. [DOI] [PubMed] [Google Scholar]
- 14.Khalid A, Haque AU. Touch impression cytology versus frozen section as intraoperative consultation diagnosis. Int J Pathol. 2004;2:63–70. [Google Scholar]










